VPGMarketResearchrsquo;s new report provides comprehensive analysis of thenbsp; POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation
Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
Fiveyear test volume and reagent sales forecasts for major infectious disease tests by market segment:
Physician Offices/Group Practices
Emergency Rooms
Ambulatory Care Centers
Surgery Centers
Birth Centers
Sales and Market Share Analysis
Sales and market shares ofnbsp;major reagent and instrument suppliers.
Infectious Disease Tests
AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,nbsp; Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis A, B, C, D, E, Herpes Simplex Virus, Human Herpes Virus6 HHV6, Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculosis, Vibrio, West Nile, Yersenia.
Technology Review
Emerging technologies and their applications for POC testing.
Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Strategic Recommendations
Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years.
Design criteria for POC testing products.
Alternative business expansion strategies.
Potential market entry barriers and risks.
Competitive Assessments
Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in Ramp;D.
The companies analyzed in the report include:
nbsp;nbsp; Abbott
nbsp;nbsp; Accriva
nbsp;nbsp; ADI/American Diagnostica
nbsp;nbsp; Agilent Technologies
nbsp;nbsp; Alere/Biosite/Inverness
nbsp;nbsp; AxisShield
nbsp;nbsp; Beckman Coulter/Danaher
nbsp;nbsp; Becton Dickinson
nbsp;nbsp; Bio/Data
nbsp;nbsp; Biomerieux
nbsp;nbsp; BioRad
nbsp;nbsp; Cepheid
nbsp;nbsp; ChronoLog
nbsp;nbsp; Corgenix
nbsp;nbsp; Decode Genetics
nbsp;nbsp; Diadexus
nbsp;nbsp; Diagnocure
nbsp;nbsp; Diagnostica Stago/Trinity Biotech
nbsp;nbsp; Diamedix/Erba
nbsp;nbsp; Diasorin
nbsp;nbsp; Eiken Chemical
nbsp;nbsp; EKF Diagnostics
nbsp;nbsp; Fujirebio
nbsp;nbsp; Grifols
nbsp;nbsp; Helena Laboratories
nbsp;nbsp; Hologic/GenProbe
nbsp;nbsp; Horiba
nbsp;nbsp; Instrumentation Laboratory
nbsp;nbsp; Kreatech/Leica
nbsp;nbsp; Kyowa Medex
nbsp;nbsp; Lonza
nbsp;nbsp; Mackay Life Sciences
nbsp;nbsp; Matritech
nbsp;nbsp; Nihon Kohden
nbsp;nbsp; OrthoClinical Diagnostics
nbsp;nbsp; Polartechnics
nbsp;nbsp; Polymedco
nbsp;nbsp; Qiagen
nbsp;nbsp; Roche
nbsp;nbsp; SDIX
nbsp;nbsp; Sequenom
nbsp;nbsp; Siemens
nbsp;nbsp; Sienco
nbsp;nbsp; Sysmex
nbsp;nbsp; Takara Bio
nbsp;nbsp; Thermo Fisher
nbsp;nbsp; Tosoh
nbsp;nbsp; Wako
nbsp;nbsp; Zycare/Alere
Methodology
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch039;s proprietary data files.
Contains 835 pages andnbsp;80 tables